National guidelines for the management of absolute cardiovascular disease risk

• Department of General Practice, University of Sydney, Sydney, NSW.

---

• 1. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. Canberra: National Vascular Disease Prevention Alliance, 2012. http://strokefoundation.com.au/site/media/AbsoluteCVD_GL_webready.pdf (accessed Feb 2013).
• 2. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559.
• 3. Makani H, Bangalore S, Desouza KA, et al. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ 2013; 346: f360
• 4. National Clinical Guideline Centre. Hypertension. Clinical management of primary hypertension in adults. NICE clinical guideline 127. London: National Clinical Guideline Centre, 2011.
• 5. Hypertension Canada. Hypertension without compelling indications. 2013 CHEP recommendations. http://www.hypertension.ca/recommendation-details (accessed Feb 2013).
• 6. Kidney Health Australia. Chronic kidney disease (CKD) management in general practice. 2nd ed. Melbourne: Kidney Health Australia, 2012.
• 7. National Aboriginal Community Controlled Health Organisation and Royal Australian College of General Practitioners. National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people. 2nd ed. Melbourne: RACGP, 2012.